News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WORLAND STEPHEN T
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Exercised 33,799 options to buy
@ $0.52, valued at
$17.6k
|
|
| 05/16/2023 |
4
| WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 6,401 shares
@ $0.459, valued at
$2.9k
|
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.47, valued at
$470k
|
|
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2022 |
4
| WORLAND STEPHEN T (President and Chief Executive) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 520,674 options to buy
@ $6.65, valued at
$3.5M
|
|
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 4,500 options to buy
@ $2.07, valued at
$9.3k
|
|
| 06/17/2019 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.635, valued at
$9.5k
|
|
| 06/13/2018 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.7, valued at
$40.5k
|
|
| 06/15/2017 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.15, valued at
$32.3k
|
|
| 06/02/2016 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 07/24/2015 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $13.02, valued at
$195.3k
Granted 6,103 options to buy
@ $13.02, valued at
$79.5k
|
|
| 02/27/2015 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Granted 18,897 options to buy
@ $13.4, valued at
$253.2k
|
|
| 06/02/2014 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 5,677 shares
@ $0 |
|
| 05/23/2013 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 14,922 shares
@ $0 |
|
| 06/15/2012 |
4
| WORLAND STEPHEN T (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.34, valued at
$108.5k
|
|
| 06/15/2012 |
3
| WORLAND STEPHEN T (Director) has filed a Form 3 on GenMark Diagnostics, Inc. |
| 12/15/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/07/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/20/2009 |
4
| WORLAND STEPHEN T (President and CEO) has filed a Form 4 on ANADYS PHARMACEUTICALS INC |
| 12/12/2008 |
4
| WORLAND STEPHEN T (President and CEO) has filed a Form 4 on ANADYS PHARMACEUTICALS INC |
|
|